Butterfly Pea — Benefits Deep Dive

Butterfly pea — Clitoria ternatea — is the rare case of a trendy herb whose most spectacular property is also its most solidly established one, and that property is not a health benefit at all. It is chemistry. The flowers contain ternatins, a family of unusually armoured blue pigments, and those pigments behave as a genuine acid–base indicator: blue in water, violet as acid is added, pink in lemon juice, and green to yellow-brown in alkali. Everything real about this plant radiates outward from that one fact.

These four pages take the four things people actually want to know and separate what is measured from what is claimed. The colour change is measured, repeatable and beautiful, and it says nothing whatsoever about what the tea does inside you — a distinction the marketing works hard to blur. The antioxidant claim rests on test-tube assays whose parent database the USDA formally withdrew in 2012 for exactly this kind of misuse, and on pigments that are poorly absorbed. The metabolic claim rests on two small, short Thai crossover trials in healthy or overweight men, which are real studies with real findings and very narrow reach. The cognitive claim rests almost entirely on rodent work using the plant's root and on an Ayurvedic drug name, shankhpushpi, that is applied to at least four different species.

None of that makes butterfly pea a bad thing to drink. It is caffeine-free, near-neutral in flavour, has centuries of culinary use across Thailand, Malaysia and Indonesia, and carries no toxicity signal at food amounts. It is simply not the nootropic on the label. Read the tier labels on each page — randomized clinical trial, preliminary (animal or in-vitro), traditional use only — and you will know exactly how much weight each statement can carry.

Table of Contents

1. Deep-Dive Articles
2. How to Read This Set
3. Key Research: Colour Chemistry and the Ternatins
4. Key Research: Antioxidant Capacity and Bioavailability
5. Key Research: Post-Meal Glucose and Blood Fats
6. Key Research: Cognition, Cholinergic Mechanism and Shankhpushpi
7. Key Research: Safety, Toxicology and Regulatory Status
8. Live PubMed Searches
9. External Resources
10. Connections

Deep-Dive Articles

How to Read This Set

Three habits make the whole literature on this plant legible, and they are worth stating before you read anything else.

First, always ask which part of the plant. Butterfly pea is effectively two herbs sharing a name. The flower is the food colouring, the blue tea and the source of the ternatins; almost all of the human research and all of the culinary history attaches to it. The root is the classical Ayurvedic drug and the material used in most of the rodent memory experiments; it has a different chemical profile entirely, including triterpenoids the flower does not supply in quantity. The seed is traditionally purgative. A claim built on root data and printed on a flower-tea packet is not a small imprecision — it is a different plant part with different constituents.

Second, always ask what the outcome was. "Raised plasma antioxidant capacity" is a laboratory reading from a blood sample. "Lowered post-meal glucose at thirty minutes" is a physiological measurement over a single afternoon. "Reduced the risk of diabetes" is a clinical endpoint that nobody has tested for this plant. These three sentences look similar on a label and are separated by decades of research effort.

Third, always ask how many people and for how long. The entire human evidence base for butterfly pea is two acute crossover trials with roughly fifteen participants each, measuring a few hours after a single drink, in men, with no clinical endpoint. That is a legitimate and useful place for a research programme to start. It is not a place from which any therapeutic claim can honestly be made.

Each sub-article labels its claims with one of three tiers:

1. Randomized clinical trial — tested in humans under controls. For butterfly pea this tier is small, acute and metabolic only.
2. Preliminary (animal or in-vitro) — a real measurement in cells, a test tube or a rodent. Informative about mechanism, silent about people.
3. Traditional use only — documented human practice over generations, which is genuine evidence of tolerability and cultural value and is not evidence of efficacy.

Key Research: Colour Chemistry and the Ternatins

This is the best-established body of work on the plant, and it is chemistry rather than medicine. The Japanese group led by Norio Terahara isolated and named the ternatin series through the 1990s; later work established how the acylated side chains stabilise the pigment and how the colour tracks pH.

1. Terahara and colleagues, Journal of Natural Products, 1996 — "Five new anthocyanins, ternatins A3, B4, B3, B2 and D2, from Clitoria ternatea flowers." The paper that established the core of the ternatin series. Find on PubMed.
2. Terahara and colleagues, Journal of Natural Products, 1998 — "Eight new anthocyanins, ternatins C1–C5 and D3 and preternatins A3 and C4 from young Clitoria ternatea flowers." Extends the series and describes the "preternatins" of immature flowers. Find on PubMed.
3. Kazuma, Noda and Suzuki, Phytochemistry, 2003 — malonylated flavonol glycosides from Clitoria ternatea petals, mapping the non-anthocyanin flavonoids that sit alongside the pigments and act as copigments. Find on PubMed.
4. Yoshida, Mori and Kondo, Natural Product Reports, 2009 — a review of how blue flower colour is produced by anthocyanins, from molecular structure through vacuolar pH and metal complexation. The best single explanation of why blue is chemically difficult. Find on PubMed.
5. Vidana Gamage, Lim and Choo, Frontiers in Plant Science, 2021 — a review of butterfly-pea anthocyanin biosynthesis, extraction, stability and applications, and the most current synthesis of the colour-stability literature. Find on PubMed.
6. Oguis, Gilding, Jackson and Craik, Frontiers in Plant Science, 2019 — "Butterfly pea (Clitoria ternatea), a cyclotide-bearing plant with applications in agriculture and medicine." The most comprehensive single review of the species, and the standard reference for its cyclotides. Find on PubMed.

Key Research: Antioxidant Capacity and Bioavailability

The critical papers here are not about butterfly pea at all. They are about what antioxidant assays mean and where anthocyanins go after you swallow them — and they are the reason the "high in antioxidants" line on a blue-tea packet cannot be taken at face value.

1. Manach, Williamson, Morand, Scalbert and Rémésy, American Journal of Clinical Nutrition, 2005 — a review of 97 human bioavailability studies of dietary polyphenols. Anthocyanins come out at the low end of absorbed compound classes. Find on PubMed.
2. Czank, Cassidy and colleagues, American Journal of Clinical Nutrition, 2013 — a carbon-13 labelled tracer study of human metabolism and elimination of cyanidin-3-glucoside. The single most informative anthocyanin pharmacokinetic study, because the label lets the metabolites be followed rather than guessed at. Find on PubMed.
3. de Ferrars and colleagues, British Journal of Pharmacology, 2014 — the pharmacokinetics of anthocyanins and their metabolites in humans, establishing that circulating phenolic acid metabolites vastly outnumber intact parent pigments. Find on PubMed.
4. Williamson and Clifford, Biochemical Pharmacology, 2017 — on the roles of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols. Explains why the compound in the cup is largely not the compound in the blood. Find on PubMed.
5. Bjelakovic and colleagues, JAMA, 2007 — a systematic review and meta-analysis of mortality in randomized trials of antioxidant supplements for primary and secondary prevention. The landmark negative result that ended the simple antioxidant hypothesis. Find on PubMed.
6. Nair and colleagues, Journal of Agricultural and Food Chemistry, 2015 — ternatin anthocyanins and quercetin glycosides from butterfly-pea petals tested against lipopolysaccharide-induced inflammation in macrophage cells. Cell-culture work; a mechanism lead, not a human finding. Find on PubMed.

Key Research: Post-Meal Glucose and Blood Fats

Two acute crossover trials from Chulalongkorn University in Bangkok are the entire human evidence base for this plant. Both are small, both are short, both are in men, and both are worth reading properly rather than being cited as "clinically proven".

1. Chusak, Thilavech, Henry and Adisakwattana, BMC Complementary and Alternative Medicine, 2018 — "Acute effect of Clitoria ternatea flower beverage on glycemic response and antioxidant capacity in healthy subjects: a randomized crossover trial." Fifteen healthy young men, five beverage conditions, three hours of sampling. Tier: randomized clinical trial, acute, no clinical endpoint. Find on PubMed.
2. Thilavech, Adisakwattana and colleagues, Biology (Basel), 2021 — butterfly-pea flower extract with a high-fat meal challenge in overweight and obese participants, reporting reduced post-meal triglyceride rise and higher plasma antioxidant status, and no change in inflammatory cytokines. Tier: randomized clinical trial, acute, mixed result. Find on PubMed.
3. Adisakwattana and colleagues, BMC Complementary and Alternative Medicine, 2012 — in-vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase. The mechanistic groundwork behind the trials above. Tier: in vitro. Find on PubMed.
4. Jeyaraj, Lim and Choo, 2021 — a review of butterfly-pea extraction methods and the biological activities reported for its phytochemicals, useful mainly for seeing how much of the literature is in-vitro. Find on PubMed.
5. Escher and colleagues, Food Research International — butterfly-pea petal bioactives tested for antioxidant, enzyme-inhibitory and LDL-oxidation effects. A wide in-vitro panel; treat every activity in it as a hypothesis. Find on PubMed.

Key Research: Cognition, Cholinergic Mechanism and Shankhpushpi

Read this block alongside the sub-article, because the species-identity problem in the fourth entry undermines a great deal of what gets cited for the cognitive claim.

1. Damodaran and colleagues, Neurochemistry International, 2020 — the nootropic and anticholinesterase activities of Clitoria ternatea root extract, proposed as a candidate for cognitive decline. Tier: preliminary (rodent). Note the plant part. Find on PubMed.
2. Rai and colleagues, early 2000s — a series of rat studies on Clitoria ternatea root extract, hippocampal acetylcholine content and dendritic arborization, reported in Fitoterapia and Indian physiology journals. Foundational to the memory claim and entirely rodent. Find on PubMed.
3. Mukherjee, Kumar, Mal and Houghton, Phytomedicine, 2007 — a review of acetylcholinesterase inhibitors from plants, which puts the butterfly-pea enzyme data in the context of how weak most botanical inhibitors are compared with licensed drugs. Find on PubMed.
4. Sharma and colleagues, Neuroscience and Biobehavioral Reviews, 2022 — an umbrella review of shankhpushpi in neurological disorders, conducted on Convolvulus pluricaulis. Essential reading precisely because it is about a different species from the one in your teapot. Find on PubMed.
5. Mukherjee, Kumar, Kumar and Heinrich, Journal of Ethnopharmacology, 2008 — "The Ayurvedic medicine Clitoria ternatea — from traditional use to scientific assessment." The standard bridge between the textual tradition and the experimental literature. Tier: review spanning traditional use and preliminary science. Find on PubMed.

Key Research: Safety, Toxicology and Regulatory Status

The honest summary of this block is that it is thin, and thin in a specific direction: there is a long culinary record and no toxicity signal, which is not the same thing as a completed safety assessment of a gram-scale daily extract.

1. Search the toxicology literature directly — the published acute and sub-chronic animal toxicity work on Clitoria ternatea extracts is sparse and mostly reports no adverse effect at the doses tested, which is a weak form of reassurance. Search PubMed.
2. Both Thai crossover trials above reported no adverse events, in roughly thirty participants total over a few hours each. That is the sum of the controlled human safety data. Search PubMed.
3. The seed and root have a traditional purgative reputation, and the relevant literature is ethnobotanical rather than toxicological. Search PubMed.
4. On the regulatory side, butterfly-pea flower extract has been evaluated as a colour additive for use in foods and beverages in the United States, and its status varies by jurisdiction and food category. Check the current position with the regulator rather than a supplier. U.S. Food and Drug Administration.
5. Butterfly pea's cyclotides are stable to heat and digestion and have insecticidal activity; their behaviour after human ingestion is not established. This is a genuine open question rather than a known problem. Search PubMed.

Live PubMed Searches

1. Clitoria ternatea — everything
2. Butterfly pea randomized controlled trials
3. Ternatin stability across pH
4. Intramolecular copigmentation in acylated anthocyanins
5. Natural blue food colourants
6. Anthocyanin bioavailability and microbial metabolites
7. Limitations of ORAC and antioxidant-capacity assays
8. Butterfly pea and carbohydrate-digesting enzymes
9. Butterfly pea, memory and learning
10. Shankhpushpi — species identity and substitution
11. Butterfly pea and hair growth
12. Anthocyanins, skin and glycation

External Resources

• NCCIH (National Center for Complementary and Integrative Health) — the U.S. government's plain-language clearinghouse on herbal products, and the right place to check how a botanical claim is officially characterised.
• NIH Office of Dietary Supplements — fact sheets on nutrients and supplement regulation, including the general framework that governs how a "blue tea capsule" can be marketed.
• PubChem — look up delphinidin, p-coumaric acid and the individual ternatins to see their structures and properties directly.
• Plants of the World Online (Kew) — the authoritative botanical record for Clitoria ternatea, its accepted name, synonyms and native range.
• U.S. Food and Drug Administration — current colour-additive and food-ingredient status for butterfly-pea flower extract.
• European Food Safety Authority — the European counterpart, for readers outside the United States.
• ClinicalTrials.gov — search "Clitoria ternatea" to see whether any registered human trial has opened since this page was written. That is the single fastest way to check whether the evidence picture here has changed.
• USDA Agricultural Research Service — the agency that published, and then in 2012 withdrew, the ORAC food database that most "antioxidant score" marketing still quietly descends from.

Connections

• All Herbs
• Butterfly Pea (Clitoria ternatea) — the main topic page: botany, names, culinary use, forms, dosage and cautions.
• Anthocyanins — the pigment class the ternatins belong to, and the wider human evidence on what anthocyanins do.
• Anthocyanins — Benefits — the deep dive on absorption, metabolism and where the anthocyanin evidence is actually strong.
• Hibiscus — the other great anthocyanin flower tea, and the one with substantially better human blood-pressure data.
• Hibiscus — Benefits — a useful contrast in how a flower tea looks when the trials do exist.
• Sacred Lotus — another Asian flower with a large traditional reputation and a small trial literature.
• Chrysanthemum — a flower tea whose colour chemistry is dull and whose traditional use is better documented.
• Bacopa monnieri — the Ayurvedic medhya herb that actually has human cognitive trials, for comparison.
• Bilberry — the anthocyanin source with the longest supplement history and its own overclaiming problem.
• Blueberries — a far richer anthocyanin source by weight than a cup of blue tea.
• Insulin Resistance — the condition the post-meal glucose findings are usually stretched to cover.

Safety and disclaimer. This page is educational and is not medical advice. Butterfly-pea flowers used as a tea or food colouring have a long culinary record and no established toxicity signal at those amounts; concentrated extracts and capsules have not been studied for long-term human use, and "no signal found" is not the same as "proven safe". Avoid concentrated extracts in pregnancy and breastfeeding, do not give supplements to children, and note that the seeds and root are traditionally purgative and are not the tea. If you take insulin, a sulfonylurea or any other glucose-lowering medication, talk to your prescriber before using concentrated butterfly-pea extract and monitor your readings. Nothing here supports replacing a prescribed medicine with a herbal product.

Back to Table of Contents